Is the administration of mineralocorticoid receptor antagonist required in asymptomatic AHA/ACC stage B heart failure patients?

Back

ESC Premium Access

Is the administration of mineralocorticoid receptor antagonist required in asymptomatic AHA/ACC stage B heart failure patients?

Session: Poster session 4 - Chronic heart failure (CHF)

Topic: Pharmacologic therapy

Speaker: Associate Professor T. Okumura (Nagoya, JP)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Takahiro Okumura

Nagoya University Graduate School of Medicine, Nagoya (Japan)

0 follower

28 more presentations in this session

Myocardial perfusion in diabetic patients with acute myocardial infarction and long term risk of heart failure development

Speaker: Doctor A. Tomasik (Zabrze, PL)

Access

Abstract

Slides

In vivo evidence of chronic myocardial inflammation in ischaemic cardiomyopathy using USPIO enhanced cardiovascular magnetic resonance

Speaker: Doctor J. Lagan (Chester, GB)

Access

Abstract

Slides

Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin amyloidosis

Speaker: Miss S. Brun (Toulouse, FR)

Access

Abstract

Slides

Aldehyde dehydrogenase 2 ameliorates cyclophosphamide-induced cardiotoxicity through detoxification of toxic aldehydes and suppression of cell death

Speaker: Doctor J. Wang (Jinan, CN)

Access

Abstract

Slides

A new echo-Doppler index to predict early myocardial toxicity secondary to chemotheraphy

Speaker: Assistant Professor S. Baratta (Pilar, AR)

Access

Abstract

Slides

Access the full session

Poster session 4 - Chronic heart failure (CHF)

Speakers: Associate Professor T. Okumura, Doctor A. Tomasik, Doctor J. Lagan, Miss S. Brun, Doctor J. Wang...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources